Long-Term Debt Volume: Sarepta Therapeutics (SRPT)

Brandmark of Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics, Inc. (SRPT) specializes in developing genetic drugs, outsourcing production to external CMO contractors, with the indicator standing at 1.00. This price chart illustrates the price action of an asset whose risks are tied to potential trial failures or insurance reimbursement issues for therapies. To avoid logistical disruptions, the company is developing close engineering ties with partners and financing the modernization of their equipment.

SRPT sarepta.com: Company Long-Term Debt in the range 07/04/2022 - 11/01/2026

Summary analytical data breakdowns for Sarepta Therapeutics Inc (SRPT)

- market price and analyst price targets:
Stock Price sarepta.com|SRPT - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Sarepta|SRPT - Enterprise Value
- balance sheet equity data:
Book Value per Share Sarepta|SRPT - Company Book Value|Market Value to Book Value sarepta.com|SRPT - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Sarepta Therapeutics, Inc.|SRPT - Long-Term Debt to Equity|Current Liabilities to Equity Sarepta Corp|SRPT - Company Total Debt|Debt to Book Capital Sarepta|SRPT - Company Long-Term Debts|Company Short-Term Debts Sarepta|Intermediate Coverage Ratio sarepta.com
- business earnings and investment ratios data:
SRPT - Net Income
Fundamental company valuation:sarepta.com SRPT
Manufactured product of Sarepta Therapeutics

Fundamental asset screening requires a precise analysis of long-term leverage to assess the issuer's financial stability. By analyzing changes in the issuer's long-term liabilities, an investor can determine the total amount of multi-year loans, which is critical for Sarepta Therapeutics, Inc. (SRPT) when financing costly validated logistics and maintaining strict temperature-controlled delivery of gene therapy products across all operational regions.

Who Sarepta Therapeutics, Inc. competes with

Company Long-Term Debts Tempus Labs TEM|QGEN - Company Long-Term Debt|Long-Term Debt Volume Ionis Pharmaceuticals, Inc. IONS|RGEN: Company Long-Term Debts|Avidity Corp (RNA) - Company Long-Term Debts|Company Long-Term Debt CRISPR Therapeutics AG|WGS: Company Long-Term Loans and Borrowings|Company Long-Term Debts RARE|BEAM - Long-Term Debt|Company Long-Term Debt Twist Bio TWST|TXG (10x) - Long-Term Liabilities|NTLA: Company Long-Term Liabilities|stoketherapeutics.com - Amount of Long-Term Liabilities|BLFS: Company Long-Term Debts|Wave Life Sciences Ltd (WVE) - Company Long-Term Debts|Company Long-Term Liabilities MAZE|SION: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PRME (Prime Medicine, Inc.)|Amount of Long-Term Liabilities TSHA|Company Long-Term Debts QURE (uniQure)|Company Long-Term Loans and Borrowings MGTX|Regenxbio - Company Long-Term Debts|Long-Term Debt Solid Corp|Ocugen, Inc. (OCGN) - Company Long-Term Debt|pacb.com - Company Long-Term Loans and Borrowings|BNTC (Benitec Biopharma) - Company Long-Term Debts|Company Long-Term Debts Design Therapeutics Inc|Company Long-Term Debt Rocket Pharmaceuticals Inc (RCKT)|FDMT: Long-Term Liabilities|Company Long-Term Debts LXEO (Lexeo Therapeutics, Inc.)|Korro Bio Inc. (KRRO) - Long-Term Debt|EDIT: Company Long-Term Liabilities|SLN - Company Long-Term Debts|PRQR (proqr.com) - Company Long-Term Liabilities|CDXS: Amount of Long-Term Liabilities|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Nautilus Biotechnology Inc (NAUT) - Long-Term Debt Volume|Company Long-Term Debts MGX|Company Long-Term Liabilities Precision BioSciences Inc. DTIL|Company Long-Term Debt Generation Bio GBIO|Long-Term Debt Volume Boundless Bio Inc (BOLD)|XCUR: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings IMNN (Imunon, Inc.)|PHIO: Company Long-Term Debts|MBIO - Long-Term Debt Volume|Company Long-Term Debt TransCode Therapeutics Inc.|Company Long-Term Indebtedness BNGO (Bionano)|Company Long-Term Debts APDN|Company Long-Term Liabilities bluebirdbio.com BLUE|ImmunoPrecise Antibodies Ltd. - Company Long-Term Liabilities|Long-Term Debt Volume Omega Therapeutics Inc (OMGA)|OMIC - Company Long-Term Debt|Long-Term Debt Volume Regulus RGLS|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|telesisbio.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Unity Biotechnology Inc. - Long-Term Liabilities